‌

US Patent 7538216 Guanidino phenylalanin compounds used as urokinase inhibitors

Patent 7538216 was granted and assigned to WILEX on May, 2009 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

May 26, 2009

Patent Application Number

10517518

Date Filed

June 5, 2003

Patent Primary Examiner

Patent abstract

The invention relates to the use of derivatives of 3-guanidinophenylalanine as urokinase inhibitors for treating malignant tumors and metastasis.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7538216 Guanidino phenylalanin compounds used as urokinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

By using this site, you agree to our Terms of Service.